Expansion momentum Quanta is rapidly expanding its U.S. commercial footprint following a $60M Series E funding, signaling growing demand and potential channel opportunities for distributors, service partners, and hospital networks.

Home dialysis push With FDA clearance for home hemodialysis and ongoing work toward home use submissions, there is a clear opportunity to target home care programs, home health agencies, and patient support services seeking scalable, bag-free dialysis solutions.

Versatile platform The Quanta Dialysis System unifies IHD, SLED, and CRRT in one compact device, enabling sales discussions with multi-care settings such as community clinics, ambulatory centers, and smaller hospitals that need versatile, cost-effective kidney replacement therapy.

Awarded credibility Royal Academy of Engineering MacRobert Award recognition enhances credibility when approaching procurement teams and health systems, supporting value-based conversations around innovation, reliability, and total cost of ownership.

Strategic partnerships Recent leadership hires and manufacturing investments point to a focus on scale and reliability for global deployment, presenting opportunities to engage with manufacturing and operations leaders, as well as potential integrators and partner networks in the U.S. and beyond.